Development and validation of an International Prognostic Score of thrombosis in World Health Organization–essential thrombocythemia (IPSET-thrombosis)
T Barbui, G Finazzi, A Carobbio, J Thiele… - Blood, The Journal …, 2012 - ashpublications.org
Accurate prediction of thrombosis in essential thrombocythemia (ET) provides the platform
for prospective studies exploring preventive measures. Current risk stratification for …
for prospective studies exploring preventive measures. Current risk stratification for …
[图书][B] How not to die: discover the foods scientifically proven to prevent and reverse disease
M Greger, G Stone - 2016 - books.google.com
'This book may help those who are susceptible to illnesses that can be prevented with
proper nutrition'–His Holiness the Dalai Lama The international bestseller, Dr Michael …
proper nutrition'–His Holiness the Dalai Lama The international bestseller, Dr Michael …
[HTML][HTML] Aspirin for primary prevention of cardiovascular disease: a meta-analysis with a particular focus on subgroups
Background The role of aspirin in primary prevention of cardiovascular disease (CVD)
remains unclear. We aimed to investigate the benefit-risk ratio of aspirin for primary …
remains unclear. We aimed to investigate the benefit-risk ratio of aspirin for primary …
Screening and primary prevention of colorectal cancer: a review of sex-specific and site-specific differences
NJ Massat, SM Moss, SP Halloran… - Journal of Medical …, 2013 - journals.sagepub.com
Background Colorectal cancer (CRC) is the second commonest cancer in England.
Incidence rates for colorectal adenomas and advanced colorectal neoplasia are higher in …
Incidence rates for colorectal adenomas and advanced colorectal neoplasia are higher in …
Aspirin and clopidogrel for prevention of ischemic stroke
RM Thomson, DC Anderson - Current neurology and neuroscience …, 2013 - Springer
This review examines the role of platelets in ischemic stroke, platelet activation mechanisms,
aspirin's rise as an antithrombotic agent, clopidogrel's appearance on the stage, a possible …
aspirin's rise as an antithrombotic agent, clopidogrel's appearance on the stage, a possible …
Validation of thrombotic risk factors in 1381 patients with essential thrombocythaemia: A multicentre retrospective real‐life study
R Stuckey, JC Ianotto, M Santoro… - British Journal of …, 2022 - Wiley Online Library
Thrombosis and haemorrhage are frequent in patients with essential thrombocythaemia
(ET). The 2016 revised International Prognostic Score for Thrombosis in Essential …
(ET). The 2016 revised International Prognostic Score for Thrombosis in Essential …
Bleeding complications in both anticoagulated and nonanticoagulated surgical patients
TL Kent, PL Custer - Ophthalmic Plastic & Reconstructive Surgery, 2013 - journals.lww.com
Purpose: This study was performed to ascertain the incidence of anticoagulant use in
oculoplastic surgical patients and the reliability of patient medication disclosure. Differences …
oculoplastic surgical patients and the reliability of patient medication disclosure. Differences …
[HTML][HTML] Interplay between genetic and clinical variables affecting platelet reactivity and cardiac adverse events in patients undergoing percutaneous coronary …
JM Siller-Matula, IM Lang, T Neunteufl, M Kozinski… - PLoS …, 2014 - journals.plos.org
Several clinical and genetic variables are associated with influencing high on treatment
platelet reactivity (HTPR). The aim of the study was to propose a path model explaining a …
platelet reactivity (HTPR). The aim of the study was to propose a path model explaining a …
Aspirin treatment and risk of first incident cardiovascular diseases in patients with type 2 diabetes: an observational study from the Swedish National Diabetes Register
N Ekström, J Cederholm, B Zethelius, B Eliasson… - BMJ open, 2013 - bmjopen.bmj.com
Objectives To investigate the benefits and risks associated with aspirin treatment in patients
with type 2 diabetes and no previous cardiovascular disease (CVD) in clinical practice …
with type 2 diabetes and no previous cardiovascular disease (CVD) in clinical practice …
[HTML][HTML] PFA-100: una nueva prueba de función plaquetaria sustituta del tiempo de sangría
G Campuzano-Maya - Medicina & Laboratorio, 2020 - medigraphic.com
RESUMEN El PFA-100, por Platelet Function Analyzer (Analizador de Función Plaquetaria)
es una nueva herramienta para la investigación de la hemostasia primaria, descrita e …
es una nueva herramienta para la investigación de la hemostasia primaria, descrita e …